Skanska to build AstraZeneca site

Premium Content

18 February 2015

A computer generated image of the new AstraZeneca science facilities in Cambridge

A computer generated image of the new AstraZeneca science facilities in Cambridge

Skanska has gained an SEK3.7 billion (€388 million) construction contract for a research and development centre for the UK-based AstraZeneca science group.

Designed by Herzog & de Meuron, the new facility in Cambridge, which will also serve as corporate headquarters, will be built on the Cambridge Biomedical Campus.

The scheme will become the company’s largest centre for oncology research, offering facilities for 2,000 employees. Work has now started on the project, which is due to be completed in 2017.

Its development follows Skanska’s latest annual results, which showed year-on-year growth to SEK145.02 billion (€15.05 billion).

WorkDry invests in pump fleet in preparation for extreme events
Company adds hundreds of new pumps in anticipation of extreme El Niño weather events.
Chinese gains reshape South American market
Chinese construction equipment manufacturers are becoming an established competitive force in South America rather than simply a low-cost alternative, according to a white paper from Off-Highway Research
Smarter by design: How intelligent excavators are delivering better jobsite results
Integrated technology is helping contractors improve accuracy, productivity and control without neglecting the fundamentals of machine performance